BIOLASE (NASDAQ:BIOL) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report report published on Friday. The brokerage issued a sell rating on the medical technology company’s stock.

Other research analysts also recently issued research reports about the company. Benchmark reiterated a speculative buy rating and set a $0.40 price target on shares of BIOLASE in a report on Wednesday, October 2nd. Ascendiant Capital Markets reduced their target price on shares of BIOLASE from $3.50 to $2.00 and set a buy rating for the company in a research note on Tuesday, September 3rd.

BIOLASE Trading Down 72.0 %

NASDAQ BIOL opened at $0.02 on Friday. BIOLASE has a 1 year low of $0.02 and a 1 year high of $1.94. The company has a market cap of $581,281.80, a PE ratio of 0.00 and a beta of 0.67. The stock’s 50-day moving average price is $0.05 and its two-hundred day moving average price is $0.10.

BIOLASE (NASDAQ:BIOL) last issued its quarterly earnings results on Thursday, August 8th. The medical technology company reported ($0.08) EPS for the quarter. BIOLASE had a negative net margin of 41.65% and a negative return on equity of 1,782.73%. The firm had revenue of $11.56 million during the quarter.

Hedge Funds Weigh In On BIOLASE

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC boosted its position in BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 143,537 shares of the medical technology company’s stock after buying an additional 131,248 shares during the quarter. Virtu Financial LLC owned approximately 0.43% of BIOLASE worth $27,000 at the end of the most recent reporting period. 8.79% of the stock is currently owned by hedge funds and other institutional investors.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.